https://de.marketscreener.com/kurs/aktie/ROCHE-HOLDING-AG-68997/news/Roche-erhalt-auch-in-EU-Zulassung-fur-MS-Mittel-Ocrevus-25797526/?utm_source=telegram&utm_medium=social&utm_campaign=share